Literature DB >> 11245028

Maternal-fetal transmission of human papillomavirus.

X Wang1, Q Zhu, H Rao.   

Abstract

OBJECTIVE: To investigate the maternal-fetal transmission of human papillomavirus (HPV).
METHODS: Samples of exfoliated cervical cells were obtained from 73 pregnant women on their third-trimester examinations. Samples of fetal membranes, amniotic fluid and nasopharyngeal swab were obtained from the parturients and their neonates. The presence of HPV types 16, 18 and 35 deoxyribonucleic acid was detected by polymerase chain reaction (PCR) and endonuclease method.
RESULTS: HPV types 16, 18 and 35 deoxyribonucleic acid were found in 26 (35.6%) of 73 specimens of cervical cells obtained from the parturients, and in 31 (42.5%) of 73 specimens of fetal membranes, 6 (15.4%) of 39 specimens of amniotic fluid, and 5 (14.7%) of 34 neonatal nasopharyngeal swabs obtained from the neonates. The restriction endonuclease analysis of the amplified products showed that HPV types 16, 18 and 35 were positive in 24.7%, 9.6% and 1.4% respectively of parturients, and 11.0%, 4.1% and 0 respectively of neonates. The maternal-fetal transmission rate of HPV was 50% (7/14) for spontaneous vaginal delivery, and 33.3% (4/12) for cesarean section.
CONCLUSION: HPV can be transmitted from mothers to their babies not only through the placenta during pregnancy, but also through the genital tract during delivery.

Entities:  

Mesh:

Year:  1998        PMID: 11245028

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  13 in total

1.  Transmission of high-risk human papillomavirus (HPV) between parents and infant: a prospective study of HPV in families in Finland.

Authors:  Marjut A M Rintala; Seija E Grénman; Mirja H Puranen; Erika Isolauri; Ulla Ekblad; Pentti O Kero; Stina M Syrjänen
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

2.  Viral invasion of the amniotic cavity (VIAC) in the midtrimester of pregnancy.

Authors:  Maria-Teresa Gervasi; Roberto Romero; Gabriella Bracalente; Tinnakorn Chaiworapongsa; Offer Erez; Zhong Dong; Sonia S Hassan; Lami Yeo; Bo Hyun Yoon; Gil Mor; Luisa Barzon; Elisa Franchin; Valentina Militello; Giorgio Palù
Journal:  J Matern Fetal Neonatal Med       Date:  2012-05-30

Review 3.  Oncogenic Papillomavirus and Polyomavirus in Water Environments: Is There a Potential for Waterborne Transmission?

Authors:  M Fratini; P Di Bonito; G La Rosa
Journal:  Food Environ Virol       Date:  2013-11-30       Impact factor: 2.778

Review 4.  Recurrent respiratory papillomatosis.

Authors:  Naren N Venkatesan; Harold S Pine; Michael P Underbrink
Journal:  Otolaryngol Clin North Am       Date:  2012-06       Impact factor: 3.346

Review 5.  Is administration of the HPV vaccine during pregnancy feasible in the future?

Authors:  Abbey B Berenson; Pooja R Patel; Alan D Barrett
Journal:  Expert Rev Vaccines       Date:  2013-11-28       Impact factor: 5.217

6.  Human papillomavirus in amniotic fluid.

Authors:  Mack T Ruffin; Joanne M Bailey; Diane Roulston; Daisy R Lee; Ruth Ann Tucker; David C Swan; Elizabeth R Unger
Journal:  BMC Pregnancy Childbirth       Date:  2006-09-04       Impact factor: 3.007

7.  Perinatal transmission of human papilomavirus DNA.

Authors:  Renato L Rombaldi; Eduardo P Serafini; Jovana Mandelli; Edineia Zimmermann; Kamille P Losquiavo
Journal:  Virol J       Date:  2009-06-21       Impact factor: 4.099

8.  Survey of human papillomavirus types and their vertical transmission in pregnant women.

Authors:  Ying Hong; Shu-Qin Li; Ya-Li Hu; Zhi-Qun Wang
Journal:  BMC Infect Dis       Date:  2013-02-27       Impact factor: 3.090

9.  Maternal transmission of human papillomavirus in retinoblastoma: A possible route of transfer.

Authors:  Anand Bhuvaneswari; V R Pallavi; R S Jayshree; Rekha V Kumar
Journal:  Indian J Med Paediatr Oncol       Date:  2012-10

10.  Transplacental transmission of Human Papillomavirus.

Authors:  Renato L Rombaldi; Eduardo P Serafini; Jovana Mandelli; Edineia Zimmermann; Kamille P Losquiavo
Journal:  Virol J       Date:  2008-09-25       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.